Medically Reviewed By: Dr. Eric Fete
Timing matters with hormone replacement therapy. Starting too late can mean years of unnecessary symptoms and preventable health decline. But starting without proper evaluation can introduce risks that could have been avoided.
The truth is, there is no single “right age” to begin BHRT or HRT – the decision depends on your symptoms, your lab work, your health history, and where you are in the hormonal transition. What the research does make clear is that earlier intervention, when clinically appropriate, tends to produce better outcomes than waiting until damage has already been done.
Hormone levels do not decline on a predictable schedule. Some women begin experiencing significant hormonal shifts in their late 30s during perimenopause, while others may not notice changes until their early 50s. For men, testosterone levels typically begin declining around age 30 at a rate of roughly 1–2% per year, but the timeline and severity vary widely depending on genetics, lifestyle, body composition, stress, sleep quality, and overall metabolic health.
The conventional medical approach has traditionally been to wait until symptoms become severe – or until a patient specifically asks for help – before considering hormone therapy. That reactive model leaves many people suffering for years with symptoms that are dismissed as “normal aging.”
A proactive, root-cause approach looks at the full picture earlier, using symptoms and lab data together to determine whether intervention is warranted before significant decline has set in.
For women, one of the most well-established principles in hormone therapy is the concept of the “timing hypothesis” or “window of opportunity.” Research consistently shows that initiating hormone therapy before age 60 or within 10 years of menopause onset is associated with the most favorable benefit-to-risk ratio.
Women who begin therapy during this window tend to experience greater benefits for cardiovascular health, bone density, cognitive function, and overall quality of life compared to those who start later.
Delaying hormone therapy beyond this window does not necessarily mean it cannot be used, but the risk-benefit calculation shifts. Women who are more than 10 years past menopause or over age 60 may still be candidates for certain forms of hormone therapy – particularly low-dose transdermal estradiol or vaginal estrogen – but the decision requires a more careful individualized assessment.
For men, there is no equivalent “window” defined in the research, but the principle of earlier intervention still applies. Men who address declining testosterone before it leads to significant muscle loss, metabolic dysfunction, bone density decline, or cardiovascular changes are in a better position to preserve their health long-term than those who wait until symptoms become debilitating.
Hormonal decline does not always announce itself with a single dramatic symptom. More often, it shows up as a gradual erosion of how you feel and function. Common signs that warrant hormone evaluation include:
Experiencing several of these symptoms does not automatically mean you need hormone therapy – but it does mean your hormones should be evaluated. Many of these symptoms overlap with thyroid dysfunction, nutrient deficiencies, metabolic issues, or chronic stress, which is why comprehensive testing (not just a single hormone level) is essential for accurate diagnosis.
Late 30s to Early 40s (Perimenopause for Women / Early Decline for Men): This is when many people first notice subtle shifts. Energy is not what it used to be. Recovery takes longer. Sleep quality changes. Weight management gets harder. Lab work at this stage can establish a baseline and identify early hormonal decline before symptoms become severe. For women, perimenopause can begin 4–10 years before menopause and is often the most symptomatic phase of the hormonal transition.
Mid-40s to Early 50s (Menopause Transition / Andropause): This is the period when hormonal decline accelerates for both men and women. Women may be experiencing significant menopausal symptoms, and men may notice more pronounced drops in energy, libido, strength, and cognitive sharpness. This is the period where the evidence for intervention is strongest – particularly for women within the first 10 years of menopause.
Late 50s and Beyond: Hormone therapy can still be appropriate for many people in this age range, but the evaluation becomes more nuanced. For women who did not start therapy during the optimal window, low-dose transdermal options or vaginal estrogen for genitourinary symptoms may be the safest approach. For men, testosterone therapy is still an option but requires careful monitoring of cardiovascular markers, hematocrit, and prostate health.
One of the most common mistakes in hormone health is waiting until symptoms are unbearable before seeking help. By the time a woman is having severe hot flashes, significant bone loss, or debilitating mood changes, years of hormonal decline have already occurred. By the time a man has lost significant muscle mass, gained visceral fat, or developed metabolic syndrome, testosterone has likely been suboptimal for a decade or more.
Hormones do not operate in isolation. When one hormone declines, it affects the entire system – metabolism, inflammation, cardiovascular health, brain function, immune response, and body composition. Addressing hormonal decline early is not about vanity or anti-aging – it is about preserving the systems that keep you healthy, functional, and resilient as you age.
The goal is not to wait for disease and then react. The goal is to identify decline early, intervene appropriately, and maintain optimal function for as long as possible.
Starting BHRT or HRT is not as simple as writing a prescription based on symptoms alone. A responsible approach includes:
At Primex Cellular Health, we believe that the best time to evaluate your hormones is before decline becomes disease. Whether you are in your late 30s noticing early changes or in your 50s dealing with full-blown symptoms, a thorough evaluation is the starting point. We offer both in-person care in Central Ohio and telemedicine consultations nationwide.
Dr. Eric Fete, DO is the founder of PrimeX, a preventive health, age management, and peak performance company that provides nutrition products, educational materials, physician grade supplements, hormone therapy and personalized health plans for maximum health, vitality, performance, and wellness.
Dr. Eric Prime-X serves patients throughout Ohio and nationwide through telemedicine.